Neurolief NAICS Code

About Neurolief

Neurolief, legally known as Neurolief Ltd., is a company based in Netanya, Israel, specializing in brain neuromodulation technology. The company has developed the world's first and only non-invasive, multi-channel brain neuromodulation system designed to treat mental health and neurological disorders. Neurolief's technology is approved by the FDA (Usa), CE (Europe), and PMDA (Japan) for the treatment of migraine. The company is currently seeking regulatory approval for its innovative therapy in the treatment of major depression. Neurolief's technology stimulates neurotransmitter release in the brainstem and modulates mood-related brain networks, providing relief for patients with major depression. The company's platform includes a wearable neuromodulation unit, a mobile app, and cloud-based data tracking and analytics, enabling personalized, at-home care.

Primary NAICS Classification

Revenue Breakdown by NAICS

Estimated revenue distribution across industry classifications:

Core Offerings

• •Mental Health Disorder Therapy Services
• •Brain Neuromodulation Technology Development
• •Cloud-Based Patient Data Analytics Development
• •Regulatory Approval Consulting for Neuromodulation Devices
• •In-Clinic Neuromodulation Therapy Services
• •Wearable Neuromodulation Device Manufacturing
• •Personalized Neurotherapy Services
• •At-Home Neuromodulation Therapy Services
• •Clinical Trial Services for Neuromodulation Therapy
• •Neurological Disorder Therapy Services
• •Global Neuromodulation Device Distribution
• •Non-Invasive Brain Stimulation System Manufacturing
• •Mobile Health Application Development

Industry Classification

Technologies

Code Crosswalks